Champions Oncology, Inc. ( CSBR) - Key Metrics
CSBR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $1.19 | -$0.02 | -$0.10 | -$0.10 |
| 2026Q2 | $1.09 | $0.02 | -$0.13 | -$0.14 |
| 2026Q1 | $1.01 | -$0.03 | $0.04 | $0.04 |
| 2025Q4 | $0.90 | -$0.13 | $0.50 | $0.48 |
| 2025Q3 | $1.24 | $0.33 | $0.04 | $0.03 |
CSBR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | -90.96 |
| 2026Q2 | ? | 78.88 |
| 2026Q1 | ? | -49.97 |
| 2025Q4 | ? | -13.40 |
| 2025Q3 | ? | 8.37 |
CSBR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | -1.36% | ? |
| 2026Q2 | -2.10% | ? |
| 2026Q1 | 0.64% | ? |
| 2025Q4 | 6.73% | ? |
| 2025Q3 | 0.30% | ? |
CSBR
Price: $6.32
52 week price:
Earnings Per Share: -0.18 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 4300
Ebitda: -4.7 millionMarket Capitalization: 78.5 million